Latest news
Pathos AI Secures Up to $2.2 Billion Global Licensing Deal for Alphamab's First-in-Class Bispecific ADC - BioPharma APACBioPharma APAC · Wed, 05 Aug 2026 18:30:31 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - medcitynews.commedcitynews.com · Tue, 04 Aug 2026 20:22:15 GMTExclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 00:00:00 GMT'Without Lena Dunham, I don’t think I’d have done stand-up' - ChortleChortle · Sat, 01 Aug 2026 21:51:38 GMT